Lutikizumab, CAS 1791411-57-8

Product Description: Lutikizumab (ABT-981) is an anti-IL-1α and IL-1β dual variable domain immunoglobulin. Lutikizumab binds and inhibits IL-1α and IL-1β. Lutikizumab can be used for the research of osteoarthritis[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Lacy SE, et al. Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-Ig(TM)) molecule that specifically and potently neutralizes both IL-1α and IL-1β. MAbs. 2015;7(3):605-19.

CAS Number: 1791411-57-8

Molecular Weight: N/A

Compound Purity: 96.54

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Interleukin Related

• Artikelnummer: MEXHY-P99721-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99721-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated